Annemieke van Zante

University of California, San Francisco

Papers

2

Total Citations

28

H-Index

2

About

Annemieke van Zante is a leading pathologist whose research focuses on the intersection of head and neck oncology, human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC), and surgical pathology. Her major contributions center on refining risk stratification and treatment de-escalation strategies for patients with HPV-positive OPSCC. In her highly cited 2021 study (21 citations), van Zante investigated the risk of pathologic extranodal extension and other adverse features following transoral robotic surgery, providing critical data to guide patient consultations and surgical decision-making. Her 2023 prospective study (7 citations) further advanced the field by demonstrating favorable quality of life outcomes in patients treated with surgery alone, supporting the paradigm shift toward less intensive, function-preserving therapies. Van Zante’s work is notable for its direct clinical impact, helping to personalize treatment plans and reduce morbidity without compromising oncologic outcomes. Through meticulous histopathologic analysis and patient-centered endpoints, she has become a key voice in the movement to tailor therapy for HPV-driven oropharynx cancer, earning recognition among surgeons, oncologists, and pathologists alike.

Research Focus

Key Achievements

2
H-Index
2
Papers
28
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer
21 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: University of California, San Francisco

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 23 days ago